Klaus Stöckemann
Fondateur chez Peppermint VenturePartners GmbH
Profil
Since April 2009 Managing Partner of the Peppermint VenturePartners GmbH.
Having joined 3i in 2000, Klaus is partner and head of 3i Germany's healthcare venture capital team.
He has more than 12 years experience in the pharmaceutical industry as Senior Manager in Research and Business Development at Schering AG in Berlin and as Director of Business Development at ASTA Medica, a Degussa & Hüls group company in Frankfurt.Klaus specialises in healthcare investments including medtech across Europe.
He represented 3i on the board of Epigenomics AG, a company developing new molecular diagnostics towards personalised medicine, until January 2005, assisting with the IPO in 2004.
He is an active partner with supervisory board roles at Jerini AG, a company that is developing new small molecule therapeutics emerging from peptidic scaffolds, Combinature Biopharm AG and Elbion AG.
He is a member of LES (Licensing European Society) and is also a fellow of the Kellogg School of Management at Northwestern University in Chicago.
Klaus holds a PhD in Biology and Pharmacology from the University of Mainz, Germany as well as an MBA from WHU / Kellogg Northwestern University in Chicago.
Postes actifs de Klaus Stöckemann
| Sociétés | Poste | Début |
|---|---|---|
Peppermint VenturePartners GmbH
 Peppermint VenturePartners GmbH Investment ManagersFinance Peppermint VenturePartners GmbH (PVP) is an independent venture capital firm founded in 2008 by Ingeborg Neumann, Dr. Joachim Rautter, and Dr. Klaus Stöckemann. It is headquartered in Berlin, Germany. | Fondateur | 08/12/2008 |
Humedics GmbH
 Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | - |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | - |
Emperra GmbH E-Health Technologies
 Emperra GmbH E-Health Technologies Medical SpecialtiesHealth Technology Emperra GmbH E-Health Technologies manufactures and designs telemedicine technologies. The firm specializes in the development of medical monitoring devices for the tracking and transmission of diabetic patients' diagnostic and therapeutic data. It develops components and systems under the ESYSTA product brand, featuring data acquisition, analysis, and transfer solutions. The company was founded by Janko Schildt in 2008 and is headquartered in Potsdam, Germany. | Président | - |
Implandata Ophthalmic Products GmbH
 Implandata Ophthalmic Products GmbH Electronic Equipment/InstrumentsElectronic Technology Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany. | Directeur/Membre du Conseil | - |
Anciens postes connus de Klaus Stöckemann
| Sociétés | Poste | Fin |
|---|---|---|
3i Deutschland Gesellschaft für Industriebeteiligungen mbH
 3i Deutschland Gesellschaft für Industriebeteiligungen mbH Investment ManagersFinance 3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors. | Private Equity Investor | 01/01/2009 |
| ASTA Medica AG | Corporate Officer/Principal | - |
| Bayer Schering Pharma AG | Corporate Officer/Principal | - |
Hematris Wound Care GmbH
 Hematris Wound Care GmbH Medical SpecialtiesHealth Technology Hematris Wound Care GmbH develops, manufactures and markets products in the field of hemostasis. Its brand Hematrix is a wound patch which is used for arterial injury-related bleeding and external bleeding caused by surgical intervention. The company was founded in 2006 by Stefan Bertsch and Hans-Georg Langer and is headquartered in Neubiberg, Germany. | Président | - |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Klaus Stöckemann
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
| WHU-Otto Beisheim School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
3i Deutschland Gesellschaft für Industriebeteiligungen mbH
3i Deutschland Gesellschaft für Industriebeteiligungen mbH Investment ManagersFinance 3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors. | Finance |
Peppermint VenturePartners GmbH
Peppermint VenturePartners GmbH Investment ManagersFinance Peppermint VenturePartners GmbH (PVP) is an independent venture capital firm founded in 2008 by Ingeborg Neumann, Dr. Joachim Rautter, and Dr. Klaus Stöckemann. It is headquartered in Berlin, Germany. | Finance |
Humedics GmbH
Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Technology Services |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
IntelliDx, Inc.
 IntelliDx, Inc. Electronic Equipment/InstrumentsElectronic Technology IntelliDx, Inc. develops medical devices. It offers automated ex vivo blood analysis systems that measure the constituents of flowing human blood, and automated blood glucose monitoring systems that measure glucose in hospitalized patients who have abnormally elevated sugar levels. The company was founded in 2000 and is headquartered in Santa Clara, CA. | Electronic Technology |
ZONARE Medical Systems, Inc.
 ZONARE Medical Systems, Inc. Medical/Nursing ServicesHealth Services ZONARE Medical Systems, Inc. designs, develops and manufactures ultrasound solutions. The firm offers ultrasound systems; curved array, curved-phased array, linear array, phased array, endocavity, and continuous wave transducers; accessories, such as transducer biopsy guides and user interface sterile covers; and upgrades, including imaging, workflow, and clinical enhancements. The company was founded by Mir A. Imran and Glen W. McLaughlin in 1999 and is headquartered in Mountain View, CA. | Health Services |
Emperra GmbH E-Health Technologies
Emperra GmbH E-Health Technologies Medical SpecialtiesHealth Technology Emperra GmbH E-Health Technologies manufactures and designs telemedicine technologies. The firm specializes in the development of medical monitoring devices for the tracking and transmission of diabetic patients' diagnostic and therapeutic data. It develops components and systems under the ESYSTA product brand, featuring data acquisition, analysis, and transfer solutions. The company was founded by Janko Schildt in 2008 and is headquartered in Potsdam, Germany. | Health Technology |
Implandata Ophthalmic Products GmbH
Implandata Ophthalmic Products GmbH Electronic Equipment/InstrumentsElectronic Technology Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany. | Electronic Technology |
Hematris Wound Care GmbH
Hematris Wound Care GmbH Medical SpecialtiesHealth Technology Hematris Wound Care GmbH develops, manufactures and markets products in the field of hemostasis. Its brand Hematrix is a wound patch which is used for arterial injury-related bleeding and external bleeding caused by surgical intervention. The company was founded in 2006 by Stefan Bertsch and Hans-Georg Langer and is headquartered in Neubiberg, Germany. | Health Technology |
| Bayer Schering Pharma AG | Health Technology |
| ASTA Medica AG | Health Technology |
